Jakarta, ThedailyID — PT Prodia Widyahusada Tbk opened 2026 with solid financial performance, posting strong profit growth despite global economic uncertainty. The healthcare provider recorded revenue of Rp501.4 billion in the first quarter of 2026. This marked a 3.8% year-on-year increase and the highest first-quarter revenue in the past two years.
Routine and esoteric diagnostic tests continued to drive demand. These segments remained the company’s main revenue contributors during the period.
Cost of revenue rose to Rp229.3 billion, up 4.4% year-on-year. The increase followed higher patient visits and testing volumes across Prodia’s network.
Net profit jumped sharply to Rp17.9 billion in Q1 2026. This reflects a 150.1% year-on-year surge, supported by revenue growth and tighter cost control.
Prodia also maintained strong operating cash flow, which reached Rp112.2 billion. The figure reflects stable operations and disciplined working capital management. Meanwhile, investment cash flow stood at negative Rp62.8 billion. The company allocated funds to expand assets and strengthen its operational ecosystem.
Total assets reached Rp2.6 trillion by the end of March 2026. This highlights Prodia’s solid financial position and ability to manage resources effectively.
Total liabilities remained low at Rp263.5 billion, while equity stood at Rp2.4 trillion. This structure shows healthy leverage and strong liquidity.
President Director Liana Kuswandi said the first quarter reflects early indicators of sector trends. Seasonal factors during Ramadan and Eid also influenced healthcare demand patterns.
She added that Prodia continues to monitor global geopolitical risks. However, these factors have not materially affected operations so far.
To sustain growth, the company is accelerating digital ecosystem development and expanding precision medicine services. Prodia recently launched new specialty clinics, including autoimmune, allergy, and stem cell facilities.
Finance & Sustainability Director Marina Eka Amalia said the company’s financial fundamentals remain strong and resilient.
She emphasized that Prodia will maintain strict cost discipline and prioritize investments with clear returns.
Beyond financial performance, Prodia continues to expand digital health services. The company introduced the Marketplace Health Shop feature on its U by Prodia app, offering verified health products and tools.
Prodia also enhanced diagnostic reporting with trend graphs and improved features for doctors. These updates aim to support better patient monitoring and clinical decisions.
The company plans to expand preventive healthcare programs, including targeting 20,000 participants for free dementia screening in 2026.
With strong fundamentals, ongoing innovation, and steady demand for diagnostics, Prodia expects to sustain growth momentum throughout the year.
